Interestingly, genetically engineered strains of E. coli are being explored for use in cancer therapy. These engineered bacteria can be designed to deliver therapeutic agents directly to tumors, enhance the immune response, or disrupt cancer cell metabolism. This innovative approach is part of a broader field known as bacterial cancer therapy.
